Mycobacteria Therapeutics is Biotechnology in United States that focus on soil-derived Immunobiotics business. Founded in 2018. They cover business area such as developer, next-generation, soil-derive immunobiotic, mental health, inflammation, medical professional, complex disease.
2018
( 6 years old in 2024 )
Soil-derived Immunobiotics
-
4324 Pecos Street
Denver, CO 80211
United States
Private
developernext-generationsoil-derive immunobioticmental healthinflammationmedical professionalcomplex disease
* We use standard office opening hours in near Mycobacteria Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Mycobacteria Therapeutics is Biotechnology business from United States that founded in 2018 (6 years old in 2024), Mycobacteria Therapeutics business is focusing on Soil-derived Immunobiotics.
Mycobacteria Therapeutics headquarter office and corporate office address is located in 4324 Pecos Street Denver, CO 80211 United States.
Mycobacteria Therapeutics was founded in United States.
In 2024, Mycobacteria Therapeutics is currently focus on soil-derived Immunobiotics sector.
Above is snippet of Google Trends for "soil-derived Immunobiotics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Mycobacteria Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
